Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03383289
Previous Study | Return to List | Next Study

Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03383289
Recruitment Status : Recruiting
First Posted : December 26, 2017
Last Update Posted : February 26, 2019
Sponsor:
Collaborators:
Cornell University
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Hebrew Home at Riverdale

Brief Summary:
Resident-to-resident elder mistreatment (R-REM) is a significant problem in long-term services and support settings (LTSS), and likely to cause physical and or psychological distress. The proposed project tests an intervention developed for use by LTSS staff. As such, it represents an important step in the process of developing approaches for ameliorating and preventing R-REM in assisted living residences which house residents with dementia and related behavioral disorders, and is thus likely to have significant public health impact.

Condition or disease Intervention/treatment Phase
Assisted Living, Resident to Resident Elder Mistreatment Other: R-REM training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1050 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Research Assistants
Primary Purpose: Prevention
Official Title: Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living
Actual Study Start Date : June 22, 2018
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : November 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dementia

Arm Intervention/treatment
Experimental: R-REM training
3 module training for frontline staff in assisted living facilities related to recognizing and management of resident-to-resident elder mistreatment
Other: R-REM training
three training modules for front-line long-term care staff to aid in recognition, management and reporting of R-REM

No Intervention: Control condition
Usual care



Primary Outcome Measures :
  1. Falls, accidents, and injuries [ Time Frame: Six months before baseline through twelve month follow-up ]
    Impact on falls, accidents, and injuries as measured by incident reports


Secondary Outcome Measures :
  1. Affect [ Time Frame: Baseline, 6- and 12- month follow-up ]
    Impact on affect as measured by the Feeling Tone Questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • all long term residents residing at each facility at baseline, for those unable to consent, proxy consent will be sought

Exclusion Criteria:

  • residents receiving hospice care,
  • facilities will have the option to exclude individuals for selected reasons, (e.g., severe psychosis)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03383289


Contacts
Layout table for location contacts
Contact: Gabriel Boratgis, MPH 718-5811134 gdborat2000@aol.com

Locations
Layout table for location information
United States, New York
Hebrew Home at Riverdale Recruiting
Bronx, New York, United States, 10471
Contact: Gabriel Boratgis, MPH    718-581-1134    gdborat2000@aol.com   
Sponsors and Collaborators
Hebrew Home at Riverdale
Cornell University
Weill Medical College of Cornell University
Investigators
Layout table for investigator information
Principal Investigator: Jeanne A Teresi, PhD, EdD Research Division, Hebrew Home at Riverdale
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Hebrew Home at Riverdale
ClinicalTrials.gov Identifier: NCT03383289    
Other Study ID Numbers: 952
First Posted: December 26, 2017    Key Record Dates
Last Update Posted: February 26, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: To be determined

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders